Methocarbamol Noumed Life Sciences (Methocarbamol)

Methocarbamol acts on the central nervous system, likely depressing neuronal activity in the spinal cord and brainstem. By inhibiting interneuronal transmission, it reduces muscle tone and the perception of pain without directly acting on the skeletal muscles themselves.

The specific dose of Methocarbamol is determined by the prescribing clinician based on the patient’s condition, age, weight, and overall health. Dosage regimens may vary, and the prescriber will provide individualized instructions.

Methocarbamol is classified as Pregnancy Category C, meaning risk cannot be ruled out. It should only be used during pregnancy if the potential benefit justifies the potential risk. Limited data are available for breastfeeding, so a healthcare professional should evaluate the safety for both mother and infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Methocarbamol is a centrally acting muscle relaxant with a relatively favorable safety profile compared with some alternatives such as baclofen or tizanidine, which may have stronger muscle‑relaxing effects but higher risks of sedation and hypotension. Choice of therapy depends on the clinical scenario and physician judgment.

Methocarbamol oral tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Methocarbamol is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious adverse reactions, though rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, hepatotoxicity, seizures, and blood dyscrasias. Patients should seek immediate medical attention if they experience rash, difficulty breathing, jaundice, or unexplained bleeding.

Methocarbamol is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is also advised for individuals with severe hepatic or renal impairment, and it should be avoided in pregnant women unless clearly indicated by a physician.